• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters1
24 results

GlaxoSmithKline LLC v. Boehringer Ingelheim Pharm

Docket 20-2926, U.S. Court of Appeals, Third Circuit (Sept. 24, 2020)
MATEY, presiding.
Statutory Actions - Other (Appeals)
Case Type3890 Statutory Actions - Other
Tags3890 Statutory Actions, Other, 3890 Statutory Actions, Other
Plaintiff - Appellee GLAXOSMITHKLINE LLC
Defendant - Appellant BOEHRINGER INGELHEIM PHARMACEUTICALS INC
cite Cite Docket
Analyze

No. 34 ORDER (AMBRO, MATEY and PHIPPS, Circuit Judges) The foregoing Motion by Appellant to file under ...

Document GlaxoSmithKline LLC v. Boehringer Ingelheim Pharm, 20-2926, No. 34 (3rd Cir. Dec. 4, 2020)
Motion to FileGranted
Present: AMBRO, MATEY and PHIPPS, Circuit Judges
Motion by Appellant to File Under Seal Volume 3 of the Joint Appendix.
Respectfully, Clerk/mcw By the Court,
The foregoing Motion by Appellant to File Under Seal Volume 3 of the Joint Appendix is granted.
Dated: December 4, 2020 MCW/cc: All Counsel of Record s/Thomas L. Ambro Circuit Judge
cite Cite Document
Analyze

No. 33 ORDER (Clerk) dismissing case pursuant to Fed. R. App. P. 42(b)

Document GlaxoSmithKline LLC v. Boehringer Ingelheim Pharm, 20-2926, No. 33 (3rd Cir. Nov. 25, 2020)
In accordance with the agreement of the parties in the above-captioned case, the matter is hereby dismissed pursuant to Fed. R. App. P. 42(b), without cost to either party.
A certified copy of this order is issued in lieu of a formal mandate.
For the Court, s/ Patricia S. Dodszuweit Clerk Dated: November 25, 2020 SLC/cc: Ms. Kate Barkman, Lisa S. Blatt, Esq. Evan R. Chesler, Esq. Jane Y. Chong, Kyle E. Gray, Esq. Christopher R. Hall, Esq. Stephen J. Kastenberg, Esq. Paul Lantieri III, Esq. Vanessa Lavely, Esq. Charles McCloud, Esq. Emelia L. McKee Vassallo, Esq. Burt M. Rublin, Esq. Matthew I. Vahey, Esq. Daniel H. Weiner, Esq.
cite Cite Document
Analyze

No. 31 ORDER (Clerk) The foregoing Motion by Appellant is referred to the merits panel

Document GlaxoSmithKline LLC v. Boehringer Ingelheim Pharm, 20-2926, No. 31 (3rd Cir. Nov. 20, 2020)
1) Motion by Appellant to File under Seal Volume 3 of the Joint Appendix
The foregoing motion is referred to the merits panel.
The Clerk will hold Volume 3 of the joint appendix provisionally under seal pending a ruling by the Court.
For the Court, s/ Patricia S. Dodszuweit Clerk
Dated: November 20, 2020 MCW/cc: All Counsel of Record
cite Cite Document
Analyze

No. 29 ORDER (MATEY, Circuit Judges) granting motion by Appellee for Extension of Time to File Its ...

Document GlaxoSmithKline LLC v. Boehringer Ingelheim Pharm, 20-2926, No. 29 (3rd Cir. Nov. 16, 2020)
1) Motion by Appellee for Extension of Time to File Its Brief Until December 1, 2020 with Request to Extend Appellant’s Reply Brief Deadline to December 14, 2020.
The foregoing Motion is GRANTED.
By the Court, s/Paul B. Matey - Circuit Judge November 16, 2020 Counsel of Record
cite Cite Document
Analyze

No. 15 ORDER (MATEY, Circuit Judge) The foregoing Unopposed Motion to Expedite Appeal with Proposed ...

Document GlaxoSmithKline LLC v. Boehringer Ingelheim Pharm, 20-2926, No. 15 (3rd Cir. Oct. 8, 2020)
Motion to ExpediteGranted
Unopposed Motion to Expedite Appeal with Proposed Briefing Schedule as follows:
Appellant’s brief to be filed on or before October 13, 2020 Appellee’s brief to be filed on or before November 6, 2020 Appellant’s brief to be filed on or before November 19, 2020 Respectfully, Clerk/slc
The foregoing Unopposed Motion to Expedite Appeal with Proposed Briefing Schedule is GRANTED.
Dated: October 8, 2020 Lmr/cc: All Counsel of Record
cite Cite Document
Analyze

No. 32

Document GlaxoSmithKline LLC v. Boehringer Ingelheim Pharm, 20-2926, No. 32 (3rd Cir. Nov. 23, 2020)

cite Cite Document
Analyze

No. 30

Document GlaxoSmithKline LLC v. Boehringer Ingelheim Pharm, 20-2926, No. 30 (3rd Cir. Nov. 17, 2020)

cite Cite Document
Analyze
1 2 3 >>